Praj Industries (Praj), announced its unaudited financial results for the quarter ended June 30, 2025
Performance review for Q1 FY26 – Consolidated:
• Income from operations stood at Rs. 6402.0 million (Q1 FY25: Rs. 6,991.4 million; Q4 FY25: Rs.8,596.9 million).
• PBT before exceptional items is at Rs. 96.09 million for the period (Q1 FY25: Rs. 788.80 million; Q4FY25: Rs. 582.52 million).
• PAT is at Rs. 53.40 million (Q1 FY25: Rs. 841.80 million; Q4 FY25: Rs. 398.17 million).
• Order intake during the quarter is Rs. 7950 million.
Commenting on the Company’s performance, Mr. Ashish Gaikwad, MD, Praj Industries said, “A cautious approach among participants in the domestic ethanol market, following the achievement of the 20% EBP target and pending new blending mandates, influenced performance in Q1FY26. Additionally, the current geo-political environment and uncertainty regarding US tariff policies have delayed capital expenditure decisions. Despite these challenges, our core fundamentals remain strong, our growth vectors are intact, and therefore we are committed to our long-term growth aspirations.”
Key developments:
• IRA Approval of 45Z/ 45Q with clarity and extension through 2029 presents a strong short to mid term opportunity for low carbon ethanol solutions
• Received order for detailed engineering of commercial size SAF plant (30 MGPA )
• Partnership with IATA, and ISMA to advance SAF Carbon Assessment and Certification in India
Praj, India’s most accomplished industrial biotechnology company is driven by innovation, integration and delivery capabilities. Over the past four decades, Praj has focused on the environment, energy, and agri-process industry, with 1000++ customer references spanning 100+ countries across all 6 continents. BioMobility® and Bio-Prism® are the mainstays of Praj’s contribution to the global Bioeconomy.
